1. Home
  2. FLWS vs IKT Comparison

FLWS vs IKT Comparison

Compare FLWS & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 1-800-FLOWERS.COM Inc.

FLWS

1-800-FLOWERS.COM Inc.

N/A

Current Price

$3.71

Market Cap

242.3M

ML Signal

N/A

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

N/A

Current Price

$2.49

Market Cap

220.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLWS
IKT
Founded
1976
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.3M
220.5M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
FLWS
IKT
Price
$3.71
$2.49
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$5.00
AVG Volume (30 Days)
170.7K
391.2K
Earning Date
05-07-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.76
EPS
N/A
N/A
Revenue
$1,151,921,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$1.33
52 Week High
$7.10
$2.61

Technical Indicators

Market Signals
Indicator
FLWS
IKT
Relative Strength Index (RSI) 37.63 58.17
Support Level $3.53 $2.31
Resistance Level $3.66 $2.53
Average True Range (ATR) 0.18 0.11
MACD -0.05 -0.01
Stochastic Oscillator 25.64 63.24

Price Performance

Historical Comparison
FLWS
IKT

About FLWS 1-800-FLOWERS.COM Inc.

1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

Share on Social Networks: